As of May 2022 Arcturus Therapeutics has a market cap of $0.47 Billion. This makes Arcturus Therapeutics the world's 5025th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.47 B | -51.53% |
2021 | $0.97 B | -8.18% |
2020 | $1.06 B | 545.71% |
2019 | $0.16 B | 238.91% |
2018 | $0.04 B | -42.22% |
2017 | $0.08 B | 45.17% |
2016 | $0.05 B | -66.56% |
2015 | $0.17 B | 238.64% |
2014 | $0.05 B | -79.18% |
2013 | $0.24 B |
On May 23rd, 2022 the market cap of Arcturus Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Nymox Pharmaceutical NYMX | $0.04 B | -91.39% | Bahamas |